How has been the historical performance of Brooks Lab.?

Answer:The historical performance of Brooks Lab shows a fluctuating trend in net sales and profitability over the past five years.

Breakdown:
Brooks Lab's net sales increased from 63.20 Cr in Mar'23 to 82.56 Cr in Mar'25, reflecting a positive growth trend. However, total operating income also saw a rise, reaching 82.56 Cr in Mar'25 from 63.20 Cr in Mar'23, despite a dip in Mar'22. The total expenditure, excluding depreciation, decreased from 105.44 Cr in Mar'22 to 77.62 Cr in Mar'25, indicating improved cost management. Operating profit (PBDIT) turned positive at 5.82 Cr in Mar'25 after experiencing significant losses in the previous years. Profit before tax also improved to 3.19 Cr in Mar'25 from a loss of 35.07 Cr in Mar'23. Despite these improvements, the net profit remained negative at 3.01 Cr in Mar'25, although it was an improvement from the losses of previous years. The company's total liabilities decreased significantly from 194.56 Cr in Mar'22 to 90.45 Cr in Mar'24, while total assets also declined from 194.56 Cr to 90.45 Cr in the same period. Cash flow from operating activities remained negative at -9.00 Cr in Mar'24, but financing activities generated a positive cash flow of 9.00 Cr. Overall, while Brooks Lab has shown signs of recovery in sales and profitability, it still faces challenges in achieving positive net profit and managing cash flow effectively.